Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Lett Appl Microbiol ; 67(3): 285-291, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29908032

ABSTRACT

Vulvovaginal candidiasis (VVC) is an inflammatory disease of the vulva and vagina caused by different yeasts of the genus Candida which is responsible for infection in pregnant patients who attended Maternidade Escola Januário Cicco, Rio Grande do Norte, Brazil. From 41 samples, 19 yeasts were identified phenotypically as Candida albicans and one as Candida glabrata which is reported as the non-albicans species most frequently isolated from vulvovaginitis. The susceptibility to selected antifungal agents (flucytosine, fluconazole, voriconazole, amphotericin B, caspofungin and micafungin) was determined, and the association between patient-related signs and symptoms aided the construction of an epidemiological profile. Antifungal susceptibility testing performed by automated method showed that all strains were sensitive to the drugs tested, including the C. glabrata specimen despite its known resistance or dose-dependent susceptibility to azole derivatives. Regarding patient signs and symptoms, no statistically significant association between these and the establishment of VVC was found. It can be concluded that the laboratorial diagnosis of VVC is necessary prior to the administration of treatment, since only 48·78% of the patients had VVC but for all of them antifungal therapy were prescribed. SIGNIFICANCE AND IMPACT OF THE STUDY: Vulvovaginal candidiasis (VVC) is a problem that affects a significant number of pregnant women worldwide. This type of fungal infection generates great discomfort due to the symptomatology and difficulties of diagnosis and treatment. In view of the scarcity of data in the State of Rio Grande do Norte, Brazil, regarding studies carried out on fungal populations of the genus Candida associated with VVC in pregnant women, this study considered relevant, the phenotypic and genotypic identification of the species, to estimate the prevalence, to determine their susceptibility to the antifungal and to correlate with signs and symptoms.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Candidiasis, Vulvovaginal/microbiology , Pregnancy Complications/microbiology , Adolescent , Adult , Amphotericin B/pharmacology , Brazil/epidemiology , Candida/genetics , Candida/isolation & purification , Candida glabrata/isolation & purification , Candidiasis, Vulvovaginal/epidemiology , Echinocandins/pharmacology , Female , Fluconazole/pharmacology , Humans , Lipopeptides/pharmacology , Micafungin , Microbial Sensitivity Tests , Pregnancy , Pregnancy Complications/epidemiology , Prevalence , Schools/statistics & numerical data , Young Adult
2.
Cell Mol Biol (Noisy-le-grand) ; 54 Suppl: OL1025-31, 2008 Jun 01.
Article in English | MEDLINE | ID: mdl-18954551

ABSTRACT

The majority of TP53 polymorphisms and cervical cancer association studies have only analyzed codon 72 polymorphism. Eight polymorphisms were reported in the region encompassing exon 2 to 4 of TP53 that codify the aminoterminal p53 region containing domains involved in the transcription transactivation and apoptosis induction. We investigated if the polymorphisms present in this region were associated with cervical cancer risk. A total of 140 samples (83 from Brazilian patients with cervical carcinoma and 57 from Brazilian healthy women) were analyzed by PCR and DNA sequencing. Only three from the eight TP53 polymorphisms described in the analyzed region were polymorphic within our samples: the 11827 base from intron 2, the 16bp duplication in the intron3 and the codon 72 (Arg>Pro) from exon 4. No statistically significant association was observed between polymorphisms from intron 2 and the 16bp duplication from intron 3 with cervical cancer. No statistically significant difference in the frequency of homozygotes for Arg in relation to other genotypes was found when comparing patient and healthy groups (OR=0.70; 95% CI= 0.31-1.56; p= 0.222). However, Arg/Pro heterozygotes were more frequent within HPV positive cancer patients than in healthy women (p=0.023; OR (Arg/Pro:Pro/Pro)= 5.82; 95% CI: 1.22-30.78; p=0.024).


Subject(s)
Exons/genetics , Polymorphism, Genetic , Tumor Suppressor Protein p53/genetics , Uterine Cervical Neoplasms/genetics , Brazil , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Humans
3.
J Pediatr (Rio J) ; 76(4): 300-4, 2000.
Article in Portuguese | MEDLINE | ID: mdl-14647660

ABSTRACT

OBJECTIVE: To determine the prevalence of rotavirus in the etiology of acute diarrhea in children from Natal city, RN, Brazil and investigate the existence or not of a seasonal distribution of this pathogen in our environment.METHODS: Fecal samples from 1,903 children (boys and girls) with ages ranging from 1 month to 10 years, living in Natal-RN, who presented acute diarrhea episodes in a period from January 1996 to December 1998, were analyzed. We searched viral particles directly in the feces by a passive agglutination reaction using anti-rotavirus specific-group monoclonal antibodies coated latex particles.RESULTS: 151 children (7.9%) of the studied population presented a positive reaction, revealing the presence of rotavirus particles in feces. Considering, however, only the children (ages from 1 to 24 months) who are more susceptible to rotavirus infection, we verified that from 1,065 examined children, 136 of them (12.8%) presented positive reaction for rotavirus, and the great majority of all children with positive reaction (96.3%) had ages ranging from 6 to 24 months. Analysis of the distribution of the cases of rotavirus infection in the three year revealed that the incidence of infection was higher in July, August, and September.CONCLUSIONS: The results indicated rotavirus infections have an important role in the etiology of acute diarrhea cases. The majority of the acute diarrhea cases positive for rotavirus occurred during the first two years of life, reaching mainly children from 6 to 24 months, with the highest incidence of infection during the months of July, August, and September.

4.
Rev Saude Publica ; 33(2): 122-8, 1999 Apr.
Article in Portuguese | MEDLINE | ID: mdl-10413929

ABSTRACT

OBJECTIVE: To verify the prevalence of the anti-HBc, anti-HBs and HBsAg markers of hepatitis B virus, and to identify the risk factors determining occupational infection with this virus among hospital personnel. METHODS: Samples of serum from 210 persons both male and female who work in different occupations at a hospital university, were analysed. The technique employed was the immunoenzymatic assay using commercial kits. RESULTS: As a control group, samples of serum from 45 volunteer blood donors were utilized. It was verified that 20.5% of the hospital personnel presented a positive reaction to at least one of the markers songht, as against 6.6% of the control group. The prevalence of each marker separately was: anti-HBc 8.1%, anti-HBs 5.2%, and HBsAg 2.9% in the hospital personnel; and 4.4%, 2.2% and 0.0% in the control group. The simultaneous presence of the anti-HBc and anti-HBs markers was detected in 4.3% of the workers. In the control group, the presence of the anti-HBc and anti-HBs markers was detected, isolately, with respective prevalences of 4.4% and 2.2%. Those who presented the highest rates of positivite reaction were: laboratory technicians 24.0%, nurses 23.6%, physicians 20.8%, and cleaning personnel 18.2%. CONCLUSIONS: The findings suggest that direct contact with patients and handling of blood and other body fluids are risk factors related to occupational infection with HBV. Therefore, it is recommended that hospital personnel be vaccinated against hepatitis B.


Subject(s)
Hepatitis B virus/isolation & purification , Hepatitis B/blood , Hepatitis B/epidemiology , Occupational Diseases/blood , Occupational Diseases/epidemiology , Personnel, Hospital , Adult , Aged , Antigens, Surface/isolation & purification , Biomarkers , Female , Hepatitis B/transmission , Hepatitis B Antibodies/isolation & purification , Hepatitis B Antigens/isolation & purification , Humans , Male , Middle Aged , Prevalence , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...